The Efficacy and Tolerability of Barnidipine Hydrochloride in Thai Patients with Hypertension

• Published in: Journal of international medical research Vol. 32; no. 2; pp. 185 - 200
• Main Authors: Buranakitjaroen, P, Koanantakul, B, Phoojaroenchanachai, M, Chawantanpipat, C
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.03.2004
• Subjects: Adult; Aged; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers - therapeutic use; Female; Humans; Hypertension - drug therapy; Hypertension - physiopathology; Male; Middle Aged; Nifedipine - analogs & derivatives; Nifedipine - therapeutic use; Placebos; Single-Blind Method; Thailand; Thailand; Barnidipine; Hypertension; Calcium-channel blocker; Efficacy
• ISSN: 0300-0605; 1473-2300
• DOI: 10.1177/147323000403200212

This open-label, blinded study was performed to evaluate the efficacy and tolerability of barnidipine at a titrated dose of 10 − 15 mg once daily for 8 weeks in the treatment of essential hypertension in 40 Thai patients. ‘Office’ blood pressure (BP) and 24-h ambulatory BP measurements were recorded. A systolic BP/ diastolic BP (SBP/DBP) reduction of 18.0 ± 13.6/9.1 ± 6.6 mmHg was obtained. The full response rate among patients with systolic and diastolic hypertension was 63% using either SBP or DBP criteria, and 54% using both SBP and DBP criteria. One of the two patients with isolated systolic hypertension had a full response, and the BP in two of the three patients with isolated diastolic hypertension was normalized. The trough-to-peak ratio and smoothness index for SBP/DBP were acceptable (0.76 ± 0.63/0.55 ± 0.26 and 1.2 ± 0.4/1.2 ± 0.3, respectively). In conclusion, once-daily barnidipine monotherapy provides effective 24-h BP control and is generally well tolerated in ambulatory patients.